. Royal DSM today held its Annual General Meeting of Shareholders.
The following items were approved:
Adoption of the Financial Statements for 2011
Adoption of the dividend for 2011 (see also separate press release)
Release from liability of the members of the Managing Board and Supervisory Board for their responsibilities in the financial year 2011
Reappointment of Mr. E. Kist as a member of the Supervisory Board
Appointment of Mrs. V.F. Haynes as a member of the Supervisory Board (see also separate press release)
Appointment of Mrs. E.T. Kennedy as a member of the Supervisory Board (see also separate press release)
Amendment of the remuneration of the Supervisory Board
Extension of the period during which the Managing Board is authorized to issue ordinary shares and to limit or exclude the preferential right when issuing ordinary shares
Authorization of the Managing Board to have the company repurchase shares
Reduction of the issued capital by canceling shares


DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

Final dividend Royal DSM
The DSM Annual General Meeting of Shareholders on 11 May 2012 passed a resolution to declare a dividend for 2011 of €1.45 per ordinary share of €1.50 par value. An interim dividend of €0.45 per ordinary share having been paid on 26 August 2011, the final dividend for 2011 will amount to €1.00 per ordinary share. With the passing of the resolution by the AGM, and in line with DSM's policy to provide a stable and preferably rising dividend, 2011 marks the second consecutive year DSM's dividend has been increased.
This final dividend of €1.00 will be paid out in cash or in the form of ordinary shares at the option of the shareholder. Dividend in cash will be paid after deduction of 15% Dutch dividend withholding tax. The ex-dividend date on NYSE Euronext will be 15 May 2012 and the record date will be 17 May 2012.
Shareholders have from 18 May until 1 June 2012 (3.00 pm CET) to indicate their choice. On 4 June 2012 after the close of trading on NYSE Euronext the number of dividend rights of ordinary shares entitling the holder to one ordinary share will be determined.
This exchange ratio will be based on the volume weighted average price of all ordinary shares in DSM traded at NYSE Euronext on 28 May 2012 up to and including 1 June 2012. The value of the stock dividend will be virtually equal to the value of the cash dividend. The ordinary shares that constitute the stock dividend are entitled to any dividend for the financial year 2012 and to the dividends for subsequent financial years. Stock dividend rights will not be traded on NYSE Euronext.

DSM appoints two new Supervisory Board members
Royal DSM today announces that its Annual General Meeting of Shareholders has approved appointing Mrs. Victoria Haynes and Mrs. Eileen Kennedy as Supervisory Board members. DSM is very pleased to announce their appointment, as they both will contribute to key areas of DSM's development as well as to the further internationalization of the company. With these appointments half of the Supervisory Board is non-Dutch and more than one third is female.

Video interviews with the new members of the Supervisory Board can be viewed at www.dsm.com
Mrs. Victoria Haynes (US nationality) is the former President and CEO of the Research Triangle Institute (RTI), an integrated multidisciplinary organization conducting research and providing services for the government, industry and universities in the areas of health, environment and education. She joined RTI from BFGoodrich Company, where she was CTO and Vice President of the Advanced Technology Group. Mrs. Haynes holds a PhD in Physical Organic Chemistry from Boston University (USA). DSM especially welcomes her broad and in-depth applied technological knowledge in the fields of Materials Sciences, Life Sciences and biotechnology, which will be important for DSM in achieving its ambitions as a leading innovative company.

Mrs. Eileen Kennedy (US nationality) is Professor of Nutrition at the Friedman School of Nutrition Science and Policy at Tufts University in Boston (USA) and Former Dean. Prior positions include Global Executive Director of the International Life Sciences Institute (Washington D.C., USA) and Under Secretary for Research, Education and Economics at the US Department of Agriculture. Mrs. Kennedy is a nutritionist and holds a Doctor of Science degree from Harvard University, School of Public Health, Nutrition Department (Boston, USA). She has been a member of the United Nations Advisory Group on Nutrition and co-chaired the US National Nutrition Summit in 2000. DSM is delighted to be gaining the benefit of Mrs. Kennedy's broad and in-depth nutrition knowledge, which will be key for DSM's growth and development.

The proposal to appoint of Mrs. Haynes and Mrs. Kennedy was first announced last October. Since then, they have familiarized themselves with the company.